ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

DPx/Patheon Sells Biologics Facility …

by Ann M. Thayer
August 3, 2015 | APPEARED IN VOLUME 93, ISSUE 31

Livia Group, a German investment company, will buy Patheon’s microbial fermentation facility in Capua, Italy. The plant has 1,400 m3 of capacity for manufacturing enzymes, therapeutic proteins, and small molecules. It serves customers in the food, feed, pharma, agrochemical, and fine chemicals industries. Patheon is a pharmaceutical contract manufacturer owned by U.S.-based DPx Holdings. It is preparing to launch as a public company.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment